News | November 03, 2021
Venus Remedies H1 net profit rises 315%
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity
Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 3rd December 2021 for a start of procedure in 2021
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
_256_384.jpg)
Both parties are expected to invest a total of US $ 1 million to establish the brand
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
Subscribe To Our Newsletter & Stay Updated
